Lockheed Martin (NYSE:LMT) just landed one of the largest single contract awards in its history. On July 29, the Department of War handed the defense giant a seven-year, up to $53.86 billion undefinitized contract action for PAC-3 Missile Segment Enhancement interceptors, pushing the total multiyear deal to $58.62 billion once the $4.7 billion awarded back in April is added in. That is not an error, which raises a clear question: what is driving this level of demand?
The answer starts with real-world consumption. Fewer than 800 Patriot missiles reportedly remain in US inventories, a stockpile a CSIS report pegs as having lost 65% of its prewar 2,330 count during the Iran conflict, leaving roughly four years of production at the old pace to cover what got burned through in under three months of fighting. Lockheed is responding by tripling PAC-3 MSE production capacity by the end of 2030 and growing its Camden, Arkansas workforce from 1,200 to about 1,850 employees. This is Lockheed's second major multiyear award under the Department's Acquisition Transformation Strategy, following the $35 billion THAAD contract, and the company is backing it with $8 billion to $9 billion in facility investment through 2030, including new munitions centers in Troy, Alabama and Camden.
A cheaper companion missile, the PAC-3 Adapted Capability Effector priced around $2.5 million versus MSE's roughly $4 million, is being positioned as complementary rather than a cannibal of MSE volume, meaning it adds revenue instead of splitting it. Layer in the $3.5 billion Ultra Maritime acquisition that expanded Lockheed into undersea defense, and a business already generating $75.1 billion in FY2025 revenue, up 5.7%, with $6.9 billion in free cash flow and a net margin near 6.7%, looks like it is compounding its core strength rather than searching for a new one.
The flip side of that strength is dependency. Roughly 72% of 2025 sales came from the US government, and the F-35 program alone accounts for about 27% of revenue, meaning any shift in Washington's spending priorities or a program delay would hit Lockheed harder than a diversified industrial company. The balance sheet carries real leverage too, with debt to equity near 3.2x and a current ratio of just 1.1x, leaving a thinner liquidity cushion than investors might expect from a company this size.
Lockheed is also fighting a $4.25 billion lawsuit over alleged technology misappropriation and regularly defends against cyberattacks aimed at its sensitive intellectual property. And when Lockheed first unveiled the cheaper PAC-3 ACE missile, investors sold the stock off on fears it would eat into MSE margins, a worry the company disputes but one that shows how sensitive the market is to anything touching this contract's economics.
#missile #roughly
The answer starts with real-world consumption. Fewer than 800 Patriot missiles reportedly remain in US inventories, a stockpile a CSIS report pegs as having lost 65% of its prewar 2,330 count during the Iran conflict, leaving roughly four years of production at the old pace to cover what got burned through in under three months of fighting. Lockheed is responding by tripling PAC-3 MSE production capacity by the end of 2030 and growing its Camden, Arkansas workforce from 1,200 to about 1,850 employees. This is Lockheed's second major multiyear award under the Department's Acquisition Transformation Strategy, following the $35 billion THAAD contract, and the company is backing it with $8 billion to $9 billion in facility investment through 2030, including new munitions centers in Troy, Alabama and Camden.
A cheaper companion missile, the PAC-3 Adapted Capability Effector priced around $2.5 million versus MSE's roughly $4 million, is being positioned as complementary rather than a cannibal of MSE volume, meaning it adds revenue instead of splitting it. Layer in the $3.5 billion Ultra Maritime acquisition that expanded Lockheed into undersea defense, and a business already generating $75.1 billion in FY2025 revenue, up 5.7%, with $6.9 billion in free cash flow and a net margin near 6.7%, looks like it is compounding its core strength rather than searching for a new one.
The flip side of that strength is dependency. Roughly 72% of 2025 sales came from the US government, and the F-35 program alone accounts for about 27% of revenue, meaning any shift in Washington's spending priorities or a program delay would hit Lockheed harder than a diversified industrial company. The balance sheet carries real leverage too, with debt to equity near 3.2x and a current ratio of just 1.1x, leaving a thinner liquidity cushion than investors might expect from a company this size.
Lockheed is also fighting a $4.25 billion lawsuit over alleged technology misappropriation and regularly defends against cyberattacks aimed at its sensitive intellectual property. And when Lockheed first unveiled the cheaper PAC-3 ACE missile, investors sold the stock off on fears it would eat into MSE margins, a worry the company disputes but one that shows how sensitive the market is to anything touching this contract's economics.
#missile #roughly
2 months ago
